Osman Osama S, Hamid Mohamed E
Gadarif Regional Institute of Endemic Diseases, University of Gadarif, Gadarif, Sudan.
Department of Microbiology and Clinical Parasitology, College of Medicine, King Khalid University, Abha, Saudi Arabia.
Am J Trop Med Hyg. 2025 Mar 18;112(6):1196-1200. doi: 10.4269/ajtmh.24-0602. Print 2025 Jun 4.
Post-kala-azar dermal leishmaniasis (PKDL) is a neglected tropical disease that can develop after treatment of leishmaniasis. It causes significant health risks and serves as a reservoir, perpetuating transmission. Current information on PKDL characteristics is crucial for effective disease management and control. This study aimed to describe clinical and epidemiological characteristics of PKDL patients in eastern Sudan. A retrospective cross-sectional study was conducted on suspected PKDL patients (N = 37) at a tertiary hospital in eastern Sudan. Blood samples were tested for anti-rK39 antibodies to confirm the diagnosis of the disease. Demographic, clinical, and epidemiological data of the PKDL patients were gathered and analyzed. Most PKDL cases (69.4%) came from specific locations involving one ethnic group (94.6%), mainly affecting young males (54.1%). A family history of PKDL was noted in only 27.0% of cases; 51.4% developed PKDL within 1 month after visceral leishmaniasis (VL) treatment. Most cases (56.8%) were grade 1 (a low level of parasitic load), predominantly featuring macular (51.4%), papular (18.9%), and nodular (13.5%) lesions. All patients had skin rashes; 91.9% exhibited no fever, and 29.7% reported itching. Lesions appeared within a month after VL treatment, with most patients recovering spontaneously within 3-18 months. PKDL was particularly prevalent in specific regions and ethnic groups, namely the Masaleet and Dago tribes. These findings can enhance PKDL understanding and management in the region.
黑热病后皮肤利什曼病(PKDL)是一种被忽视的热带疾病,可在利什曼病治疗后发生。它会带来重大健康风险,并作为传染源,使疾病传播持续存在。目前关于PKDL特征的信息对于有效管理和控制该疾病至关重要。本研究旨在描述苏丹东部PKDL患者的临床和流行病学特征。对苏丹东部一家三级医院的疑似PKDL患者(N = 37)进行了一项回顾性横断面研究。检测血样中的抗rK39抗体以确诊该疾病。收集并分析了PKDL患者的人口统计学、临床和流行病学数据。大多数PKDL病例(69.4%)来自涉及一个民族(94.6%)的特定地点,主要影响年轻男性(54.1%)。仅27.0%的病例有PKDL家族史;51.4%在内脏利什曼病(VL)治疗后1个月内出现PKDL。大多数病例(56.8%)为1级(寄生虫载量低),主要表现为斑疹(51.4%)、丘疹(18.9%)和结节(13.5%)病变。所有患者均有皮疹;91.9%无发热,29.7%有瘙痒症状。病变在VL治疗后1个月内出现,大多数患者在3 - 18个月内自发康复。PKDL在特定地区和民族中尤为普遍,即马萨利特部落和达戈部落。这些发现可增进对该地区PKDL的了解和管理。